| Novartis Pharma Schweiz AG - Mayzent 1.00 mg, Filmtabletten | | 67230 | | 03 | | Mayzent 1.00 mg | | Filmtabletten | | L04AE03 | | Siponimod | | 29.11.2023 | | |
| | Composition | | siponimodum 1 mg ut siponimodi fumaras, lactosum monohydricum 61.363 mg, cellulosum microcristallinum, crospovidonum, glyceroli dibehenas, silica colloidalis anhydrica, Überzug: poly(alcohol vinylicus), talcum, lecithinum ex soja, xanthani gummi, E 171, E 172 (rubrum), E 172 (nigrum), pro compresso obducto. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Siponimodum | 1 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Siponimodum | 1 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Nigrum) | | | | (Rubrum) | | | | Cellulosum Microcristallinum | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Glyceroli Dibehenas | | | | Lactose Monohydrate | 61.363 mg | | | Lecithinum ex Soja | | | | Poly(Alcohol Vinylicus) | | Überzug | | Pro Compresso Obducto | | | | Silica Colloidalis Anhydrica | | | | Talcum | | | | Xanthani Gummi | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 004 | 28 | 1253.44 | 1379.60 | B | LS | Non |
|
|
